𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intravenous corticotrophin vs. Hydrocortisone in the treatment of hospitalized patients with Crohn's disease: A randomized double-blind study and follow-up

✍ Scribed by Alexander Chun; Ron M. Chadi; Dr. Burton I. Korelitz; Thomas Colonna; Joseph B. Felder; Mark H. Jackson; Eric H. Morgenstern; Steven D. Rubin; Andrea G. Sacknoff; Gilbert M. Gleim

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
487 KB
Volume
4
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Ciprofloxacin or metronidazole for the t
Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: A randomized, double-blind, placebo-controlled pilot study
✍ Kelvin T. Thia; Uma Mahadevan; Brian G. Feagan; Cindy Wong; Alan Cockeram; Alain πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 99 KB πŸ‘ 1 views

Background: Although metronidazole and ciprofloxacin are used to treat perianal Crohn's disease (CD), no placebo-controlled trials have been performed. ## Methods: We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of metronidazole and ciprofloxacin in patients with

Double-frequency Nd:YAG laser vs. argon-
Double-frequency Nd:YAG laser vs. argon-green laser in the treatment of proliferative diabetic retinopathy: Randomized study with long-term follow-up
✍ Bandello, Francesco; Brancato, Rosario; Lattanzio, Rosangela; Trabucchi, Giusepp πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 403 KB πŸ‘ 2 views

## Background and objective: A randomized clinical trial using the argon-green (514 nm) and the double-frequency nd:yag (532 nm) lasers was carried out on 42 eyes with proliferative diabetic retinopathy (pdr), with the aim of assessing the long-term effects of double-frequency nd:yag panretinal pho

End-of-dose akinesia after a single intr
End-of-dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients: A pharmacokinetic/pharmacodynamic, randomized, double-blind study
✍ Nicolas Simon; JoΓ«lle Micallef; Jean-Charles Reynier; Monique Lesourd; Tatiana W πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 130 KB

## Abstract This randomized, double‐blind trial was designed to define the possible relationship between piribedil plasma concentrations and the decrease of the Unified Parkinson's Disease Rating Scale (UPDRS) motor score or the switch from __off__ to __on__ state after single intravenous infusion.

Effects of zinc supplementation on the s
Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: Follow-up of a double-blind randomized study with subgroup analysis
✍ Yung-Song Lin; Li-Ching Lin; Shih-Wei Lin πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 111 KB

## Abstract ## Objectives/Hypothesis: Dietary zinc has been reported to have positive effects on treating carcinoma. This study examined the effects of zinc supplementation on the improved survival of patients with advanced nasopharyngeal carcinoma receiving concomitant chemotherapy and radiothera

A multicentre, randomized, double-blind,
A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study
✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 139 KB πŸ‘ 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre